Remote Patient Monitoring and Digital Therapeutics for Heart Failure
Author Information
Author(s): Mavragani Amaryllis, Sharma Abhinav, Dunn Patrick, Marier-Tétrault Emmanuel, Bebawi Emmanuel, Béchard Stéphanie, Brouillard Philippe, Zuchinali Priccila, Remillard Emilie, Carrier Zoé, Jean-Charles Loyda, Nguyen John Nam Kha, Lehoux Pascale, Pomey Marie-Pascale, Ribeiro Paula A B, Tournoux François
Primary Institution: Centre Hospitalier de l’Université de Montréal
Hypothesis
Can a combined remote patient monitoring and digital therapeutics solution improve heart failure management?
Conclusion
The study showed that integrating a digital solution for heart failure management is feasible and may reduce hospitalizations and improve quality of life.
Supporting Evidence
- Patients using the app had a lower hospitalization rate compared to those who did not.
- Quality of life improved significantly for patients who were compliant with the app.
- 47% of patients in the intervention group used the app for more than 80% of the study period.
Takeaway
This study tested a new way to help heart failure patients by using technology to monitor their health and suggest treatments, which seemed to work well.
Methodology
A 3-month pre-post pilot study with heart failure patients using a mobile app for monitoring and digital therapeutics.
Limitations
The study was not powered and lacked a control group, limiting the ability to assess the true impact of the intervention.
Participant Demographics
Patients aged 65 and older with heart failure, mostly NYHA class II, with a mean age of 69.28 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website